CLICK Announces Launch of Cannabis-Based Mouth Spray
Innovative New Product Line Now Available at Select California Dispensaries and Delivery Services
LOS ANGELES, CA, April 14, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE – From the land of sunshine and movie stars comes the latest in cannabis innovation for people who want the best cannabis has to offer. CLICK™, a Southern California-based consumer lifestyle sublingual cannabis company, today announced that its inaugural line of sublingual cannabis-based sprays is now available at select dispensaries and delivery services throughout California.
CLICK is for everyone. It’s for people who just want to feel good regardless of the situation or time of day. It’s about living life to the fullest while feeling completely normal. CLICK is for millennials, boomers and everyone in between. From artists and entrepreneurs to gig workers and those trying to capture their dream, CLICK has something for everyone.
Backed by industry insiders, CLICK simplifies the cannabis experience. Simply spray under the tongue and feel effects in as little as six to eight minutes. CLICK’s unique formulation offers control for how much cannabis our customers consume, and the discreet patent-pending bottle design allows CLICK to go wherever they go.
“Right now we have an opportunity to move away from the stigma of administering cannabis by smoking and vaping to a much cleaner, discrete and fun way of experiencing the benefits,” said CLICK Director of Marketing Jared Gray. “As cannabis becomes a larger part of mainstream culture, we hope CLICK will empower consumers to navigate the rapidly growing industry with confidence.”
Each bottle of CLICK is packed with 200mg of cannabinoids which delivers 80 2.5mg sprays in total. The inaugural line features four great-tasting products:
- GO THC – Pep-A-Mint Flavor with Green Tea Extract: Made with the highest grade of THC and paired with uplifting icy-cool peppermint and all-natural green tea extract, GO is perfect for people who want the active and energy-enhanced effects that cannabis can provide.
- RESTORE 1:5 – Lemon Ginger Grass Flavor with Boswellia: Custom-built for those who want to restore their body through the power of cannabis and other natural products, RESTORE strategically combines several ingredients such as THC, CBD, revitalizing all-natural lemongrass extract, calming ginger, and anti-inflammatory Boswellia.
- CHILL 2:1 – TropiCali Flavor with L-Theanine: CHILL uses the synergy between the antioxidant and immunity-boosting properties of all-natural pineapple extract and the probiotic powerhouse effects of mango, as well as L-theanine for heart and brain health and the Vitamin B and C rich properties of passion fruit, to achieve the perfect blend for those looking for a “whole-lotta-relax” in a super small dose.
- DREAM 1:2 – Midnight Mint Flavor with Melatonin: Fall into a deep sleep with the deep-sleep inducing effects of melatonin and aromatic and digestive-aids found in spearmint along with THC and CBD. DREAM is designed to give you the rest you deserve.
Along with industry veterans, professional athletes and influencers; the Company will continue to seek additional investment from proven and strategic investors dedicated to pursuing the vision of a healthier and easier way to consume cannabis.
Founded in California, CLICK™ is an innovative leader in cannabis sublingual offerings. Its products are specifically designed to complement its customers’ lifestyle with their fast-acting features, great taste and ability to fit in the palm of your hand. When sprayed under the tongue, CLICK™ products deliver approximately 2.5mg of cannabis with each pump. Consumers will feel the effects of any of the four formulations GO, RESTORE, CHILL, and DREAM in as little as six to eight minutes. As small as a tube of chapstick, CLICK™ is discreet and designed to join you wherever life leads.Innovative New Product Line Now Available at Select California Dispensaries and Delivery Services LOS ANGELES, CA, April 14, 2020 (GLOBE NEWSWIRE) — …
Marijuana Mouth Spray: Will Cancer Pain Reliever Be Abused?
By Rachael Rettner 31 January 2012
The medical marijuana drug Sativex, which could be approved in the United States in the coming years as a treatment for pain relief, has little potential for abuse, experts say.
The British pharmaceutical company GW Pharmaceuticals is currently testing the drug, which is delivered as a mouth spray and called Sativex, in clinical trials. The company plans to seek U.S. Food and Drug Administration approval for the drug as a treatment for cancer pain when the trials are completed, likely sometime in 2014, a spokesperson for GW Pharmaceuticals told MyHealthNewsDaily.
The active ingredients in Sativex, known as cannabinoids, are derived from the cannabis plant. It is the first marijuana-based drug to be made by extracting the compounds from the plant, rather than synthesizing them. Two other drugs, Marinol and Cesamet, based on synthetic cannabinoids, were approved by the FDA in the 1980s.
Because the drug contains THC, the ingredient primarily responsible for marijuana’s “high,” it’s possible people would use the drug for recreational rather than medical purposes.
“There is no doubt in my mind that there will be people that abuse it,” said Dr. Jeffrey Bernstein, director of the Florida Poison Information Center at the University of Miami Miller School of Medicine.
However, because the drug is delivered through ingestion, rather than smoking, it would take much longer to have an effect — at least an hour, compared with the minutes it takes to get high after smoking marijuana, said Margaret Haney, a professor of clinical neurobiology at Columbia University. This means drug users seeking a high would be less likely to abuse it. “Smoking is a really effective way to get a chemical into the brain,” Haney said. The mouth spray “is a far safer administration,”she said.
And Marinol and Cesamet, which are also administered orally, have a low rate of abuse. “We don’t see a lot of problems from [those],” Bernstein said.
Not the same high
GW Pharmaceuticals intends to market Sativex in the United States for treatment of cancer pain. The drug is already approved in United Kingdom, Spain, Canada and New Zealand to treat muscle spasms due to multiple sclerosis, according to the company website.
Patients can adjust the dose of Sativex to prevent it from entering the blood too rapidly, allowing them to experience symptom relief without the marijuana high, according to GW Pharmaceuticals.
In addition, while marijuana is a hodgepodge of about 64 different substances, Sativex is composed mainly of two ingredients: THC and another cannabinoid called CBD. The latter component is thought to ameliorate some of the side effects of THC, including the high that marijuana users feel, said Dr. Armando Villarreal, an assistant professor of neurosurgery and pain management at the University of Rochester Medical Center in New York.
And for habitual marijuana users, the cultural and ritualistic practices that go along with smoking pot, such as passing a joint, may be an important part of the experience, Bernstein said. These rituals cannot be replicated with the spray. “A lot of people that smoke marijuana would rather smoke it,” he said.
Unlike drugs such as painkillers, which come with a risk of death if people take too much, patients who “overdose” on the marijuana spray would be at little risk for acute health problems, Haney said.
“What could happen is the person could get very uncomfortably intoxicated,” Haney said. But in terms of other serious health effects, “there’s none that I know of,” Haney said.
“Marijuana, in the scheme of things, is a relativity safe drug,” Bernstein said. “Even as a smokeable drug of abuse, it’s relatively safe…compared to cocaine or heroin.”
However, Villarreal noted that for people with psychiatric disorders, smoking marijuana has been shown to make the patients’ mental problems worse. It’s possible Sativex may also cause this problem in some patients, he said.
Could it help patients?
So far, the studies that have been conducted do not provide enough evidence to say Sativex is effective in improving pain symptoms, Villarreal said.
Sativex has mainly been tested as a drug to treat pain caused by damaged nerves. If the drug is approved by the FDA, Villarreal speculated, its use could be restricted to certain pain patients. Those with cancer pain that is not caused by damaged nerves may not be candidates for the drug, Villarreal said.
About 1 in 11 people who try pot end up addicted to it, Haney said. It would be interesting to study whether Sativex could help people in dependent marijuana users quit the drug, she said.
Pass it on: Because it takes longer for people to get high from an oral form of marijuana, there is little potential for abuse of a marijuana-based mouth spray.
This story was provided by MyHealthNewsDaily, a sister site to LiveScience. Follow MyHealthNewsDaily staff writer Rachael Rettner on Twitter @RachaelRettner. Find us on Facebook.The medical marijuana drug Sativex, which could be approved in the United States as a treatment for pain relief, has little potential for abuse, experts say. ]]>